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Abstract P450 was purified from microsomal fractions of a 
strain of Saccharomyces cerevisiae which contained detectable 
P450 despite the disruption of CYP51AI. The P450 had a molec- 
ular mass of 58 kDa, similar to P450 51A1, and in a reconstituted 
assay with rabbit NADPH-P450 rednctase and dilauryl 
phosphotidylcholine exhibited activity for conversion of ergosta- 
5,7-dienol into ergosterol. N-Terminal amino acid sequencing of 
the purified protein corresponded to the translated sequence of 
P450 61 which was recently identified during sequencing of chro- 
mosome XIII. This allowed the function of this family of P450 
to be identified as sterol AZ2-desaturation in the pathway of ergos- 
terol biosynthesis. 
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In this study we undertook the purification of the residual 
P450 of vegetative yeast from the strain lacking sterol 14~- 
demethylase, xamined its spectral properties and reconstituted 
activity. This enabled the identification of  its sterol 22-desatu- 
rase activity and allowed the function of the recently identified 
P450 61 family to be established. 
2. Materials and methods 
2.1. Strains 
Saccharomyces cerevisiae strain DK2 was used [4] as the source of 
microsomal P450. It is a haploid strain containing a gene disrupted 
sterol 14~-demethylase (ACYP51A1; ergll) and a suppressor mutation 
in sterol AS'6-desaturase (erg3) which allows the sterol 14ct-demethylase 
disruptant to grow aerobically by changing the sterol accumulating to
14~-methylfecosterol [4]. Additional auxotrophic markers include/eu 
23,2-112 trp 1~89 his3-A1. 
1. Introduction 
Fhe cytochrome P450 superfamily catalyse a wide range of 
di.Jerse monooxygenase r actions including endogenous and 
xcnobiotic substrates [1]. Eukaryote P450s are primarily lo- 
cated in the endoplasmic reticulum and of the range of P450 
activities, one is common to animals, plants and fungi, that is 
st~rol 14ct-demethylase [2]. Studies on P450 from Saccharomy- 
c~ cerevisiae identified a single form of P450 following purifi- 
cation from cells grown under semi-anaerobic conditions [3] 
exhibiting sterol 14e-demethylase activity, but confirmation of 
the presence of an additional P450 in significant quantities in 
w getative yeast arose from studies on strains containing a gene 
disruption for sterol 14~-demethylase (P450 51A1). Micro- 
s~ mal  fractions of this strain were analysed and found to con- 
rain P450 [4]. Another P450 gene had been identified in Sac- 
ciaromyces cerevisiae involved in dityrosine formation in 
srorulating cells [5], but this was sporulation specific and un- 
likely to be that observed during vegetative growth. Carbon 
monoxide inhibition studies and the use of the P450 inhibitors 
metapyrone and SKF525A have demonstrated another step in 
elgosterol biosynthesis was likely to be undertaken by a P450, 
o le  of the final steps in ergosterol biosynthesis involving 22- 
&:saturation [6]. The introduction of the double bond to pro- 
d ice ergosterol, rather than ergosta-5,7-dienol (Fig. 1), appears 
important for membrane function as indicated by reduced via- 
b,lity of yeast containing such sterol when confronted by os- 
not ic  stress. 
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2.2. Media and cultivation 
The strain was grown on complex medium containing 10% (w/v) 
glucose, 2% (w/v) Difco bacto-peptone and 1% (w/v) Difco yeast ex- 
tract. Cultures were grown at 30°C and plate cultures contained 2% 
(w/v) Difco Bacto-agar and only 2% (w/v) glucose. In preparation of 
biomass for enzyme purification yeast was grown in 2 litre cultures, 
contained in 3 litre flasks, and shaken at 150 rpm. Cells were inoculated 
at 106 cells/ml and harvested at 5 x 108cells/ml. 
2.3. Chemica& 
Unless specified all chemicals were obtained from Sigma Chemical 
Co., Poole, Dorset. 
2.4. Cell breakage and protein purification 
Cells were harvested at 5 x 108 cells/ml and biomass from a 2 litre 
culture resuspended in 25 ml of buffer 1 (20% (w/v) glycerol 100 mM 
potassium phosphate 1mM EDTA, pH 72). 20 g of glass beads were 
mixed with the cells and they were homogenised using a Braun MSK 
homogenisor (Braun GmbH) operating at 4000 rpm with 4 × 30 s bursts 
and liquid carbon dioxide cooling. Cell debris, unbroken cells and glass 
beads were recovered by centrifugation at1500 x g for 10 min. All steps 
after breakage were undertaken at 4°C. Mitochondria were removed 
by centrifugation at 10,000 x g for 20 rain, followed by a 100,000 x g 
spin for 1 h to produce the microsomal pellet containing P450. The 
microsomal P450 was resuspended by homogenisation in buffer 1 to a 
final concentration of protein of approximately 10 mg/ml and micro- 
somal suspensions were stored at -80°C until use. Protein concentra- 
tion was estimated using a Sigma BCA kit and P450 concentration was 
determined by reduced carbon monoxide difference spectroscopy ac- 
cording to Omura and Sato [7] using a Philips PU8800 scanning spec- 
trophotometer. 
50 nmol of microsomal P450 was solubilised in 25 mM potassium 
phosphate buffer, pH 7.2, containing 1% (w/v) sodium cholate for 1 h 
at 4°C. Solubilised P450 was recovered after a 1 h centrifugation at
100,000 x g and diluted with a 20% (w/v) glycerol solution to 25 mM 
potassium phosphate, 0.8% (w/v) sodium cholate. 
The supernatant was applied to an amino-octyl agarose column 
equilibrated with a 10 mM potasssium phosphate, pH 7.2, buffer con- 
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Fig. 1. The conversion of ergosta-5,7-dienol t  ergosterol. In the normal pathway 22-desaturation may precede the 25(28)-reduction. 
Table 1 
Summary of the purification of P450 from microsomes obtained from 
the S. cerevisiae strain DK2 
Step Total Specific Yield 
content content (%) 
(nmol) (nmol/mg) 
Microsomes 50 0.8 100 
AO-agarose luate 28 8.0 56 
Bio-gel HT eluate 10 16.5 36 
taining 0.8% (w/v) sodium cholate. The column was washed with 100 
ml of 10 mM potassium phosphate buffer, pH 7.2, containing 0.8% 
(w/v) sodium cholate, by a second 200 ml wash with a similar buffer 
containing 1.2% (w/v) sodium cholate and a third wash with 100 ml of 
100 mM potassium phosphate buffer containing 0.5% sodium cholate. 
P450 was eluted from the column with 100 mM potassium phosphate, 
pH 7.2, buffer containing 0.5% (w/v) sodium cholate and 0.5% (v/v) 
Tween 20. P450 containing fractions were pooled and dialysed over- 
night against 1 litre of 10 mM potassium phosphate buffer, pH 6.8, 
containing 0.3% (w/v) sodium cholate. The sample was then loaded 
onto a hydroxylapatite column equilibrated with 10 mM potassium 
phosphate pH 6.8. The column was washed with 10 mM potassium 
phosphate, pH 6.8, and eluted using a 10-150 mM phosphate gradient. 
P450-containing fractions (assessed by reduced carbon monoxide dif- 
ference spectroscopy) were pooled, concentrated and enzyme purity 
assessed by SDS-PAGE and specific content. Purified enzyme was 
stored at -80°C until use. 
2.5. SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE) was carried out according to Laemmli [8] using a Mini-protean 
Biorad apparatus and carbonic anhydrase (Mr -- 29,000), egg albumin 
(Mr = 45,000), bovine albumin (Mr = 66,000) and rabbit phosphorylase 
C (Mr = 97,400) as molecular mass standards. 
2.6. Reconstitution of sterol A22-desaturase activity 
Each reaction mixture contained purified P450 (0.5 nmol) and 1 U 
of rabbit NADPH-cytochrome P450 reductase (a gift from Prof. M. 
Akhtar) in a total volume of 50 ill. To this, 50/~g dilauroylphosphati- 
dylcholine (DLPC) was added and the reaction volume adjusted to 950 
/11 with 100 mM potassium phosphate buffer, pH 7.2. Ergosta-5,7- 
dienol was added at the appropriate concentration and the mixture 
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Fig. 2. (a) Reduced carbon monoxide difference spectrum of P450 
purified from DK2. (b) SDS-PAGE analysis of purified P450 (2/.tg) 
from S. cerevisiae strain DK2 using a 10% polyacrylamide gel and 
staining the protein with Coomassie blue. 
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Fig. 3. Gas chromatography of substrate (a) and after reconstitution fP450 activity (b) showing the conversion of ergosta-5,7-dienol t  ergosterol, 
to,.~,ether with characteristic mass spectra. 
soaicated until a white suspension had formed. Ergosta-5,7-dienol was 
purified from a polyene-resistant erg5 mutant of S. cerevisiae [9,10]. 
N %DPH was added at a concentration f 23 mM to the mixture to start 
the reaction. All reactions were incubated at 37°C for 2 h in a shaking 
w~ter bath. In control experiments he involvement ofP450 was exam- 
ined by bubbling carbon monoxide through the enzyme preparation 
prior to substrate addition for 2 min and also by not adding P450 or 
N x, DPH to the reconstituted system. 
Following the reconstitution of the P450 system as described above 
st,..rols were extracted using 3 ml of methanol, 2 ml (0.5% w/v) of 
p.~ rogallol in methanol and 2 ml of 60% potassium hydroxide (in water), 
in,cubated at 90°C for 2 h in a preheated water bath. After cooling the 
sa ponified mixture was extracted with 3 × 5 ml hexane and dried under 
mtrogen. A Hewlett/Packard GC/MS was used to confirm sterol iden- 
tities. An Ultra 1 capillary column was used (10m×0.2 i.d.) on a 
temperature programme 50°C (1 min) increased by 40°C/min to 290°C 
with a run time of 17 min. Injection port temperature was 280°C 
(s~91itless) and the carrier gas was helium at 40 kPa. 
2 z. N-Terminal amino acid sequencing 
The amino acid sequence of purified P450 blotted onto PVDF mem- 
bzanes were determined by sequential Edman degredation using an ABI 
4'6A sequencer. Phenylthiohantoin derivatives were analysed with an 
oMine detector calibrated with 12 pmol of each PTH amino acid. 
3, Results 
Microsomal P450 from strain DK2 exhibited a reduced car- 
bon monoxide difference spectrum with a peak at 448 nm [4] 
as is typical of yeast strains with a wild-type CYP51A1.  When 
compared to DK1, an isogenic strain from the same tetrad used 
fit the disruption, but lacking the P450 51A1 disruption, no 
difference was detected in the specific content of P450. Follow- 
ing growth in 10% (w/v) glucose the content of P450 in DK2 
was 82 + 3 pmol/mg microsomal protein in comparison to 
85 + 6 pmol/mg microsomal protein for the isogenic sister 
strain retaining P450 51A1 and isolated from the same tetrad 
dissection. 
50 nmol microsomal P450 was accumulated from 20 litre 
culture and purification undertaken. The results are presented 
in Table 1 indicating a 25% yield was obtained after both 
chromatography steps with a specific content of 16.5 nmol/mg 
protein for the pure protein. The reduced carbon monoxide 
difference spectrum of the pure protein is shown in Fig. 2a with 
a maximum apparent at 448 nm. Upon SDS-PAGE, the puri- 
fied preparation gave a single protein band with an apparent 
Mr of 58,000 (Fig. 2b). 
The reconstituted assay for metabolism of ergosta-5,7-dienol 
by the purified P450 was analysed by capillary GC analysis of 
sterol extracts from the reaction (Fig. 3). The identity of the 
sterol peaks was confirmed by mass spectrometry and showed 
conversion of the substrate into ergosterol. Control experi- 
ments showed complete carbon monoxide inhibition and P450 
and NADPH dependancy for the reaction. 
Amino acid sequence determination of the N-terminus of the 
P450 yielded the sequence 5'-TAFSILDXLKS-Y.  The order of 
MSSVAENIIQHATHNSTLHQLAKDQPSVGVTTAFSILDTLKS 
Fig. 4. The translation of the DNA sequence assigned to P450 family 
61 with the corresponding N-terminal region of the purified protein in 
bold. 
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these amino acids was observed for a yeast P450 which has been 
assigned to the P450 family 61 ([13]; Nelson, personal commu- 
nication). This was identified uring DNA sequencing of chro- 
mosome XIII and the amino acid sequence determined here 
corresponded to residues 32-42 of the open reading frame from 
the first ATG identified previously (Fig. 4) [I 3]. 
4. Discussion 
The purification of residual P450 from S. cerevisiae has been 
undertaken and shown to be active in sterol 3=-desaturation. 
The characteristics are similar to that reported previously by 
Yoshida and Aoyama for sterol 14~-demethylase [3] in that 
firstly they have a reduced carbon monoxide difference Soret 
peak at 448 nm and secondly the apparent molecular mass 
appears to be the same, 58,000 on SDS-PAGE. 
The P450 purified was active in sterol A22-desaturation a d 
this is the endogenous function of the protein. The specific 
content of P450 in the microsomal fraction of vegetatively 
growing DK2 was unaltered from that observed without gene 
disruption of CYP51A1 suggesting either that the regulation of 
P450 production was altered or that the sterol 14a-demethylase 
comprised a minor part of the microsomal P450 when grown 
under the conditions used. The correlation of the N-terminal 
sequence of the P450 purified here to a peptide sequence pres- 
ent in the P450 61 sequence deposited recently links the family 
to an endogenous function. The reason the N-terminus begins 
with the thirty-second amino acid is unclear. Possible explana- 
tions include post-translational modification, although nor- 
mally only removal of methionine might be anticipated, or 
degradation of the protein. The extent of the consensus in a 
non-conserved region of P450s makes us conclude that the 
purified protein and P450 61 are the same. 
Studies are now beginning which will address the importance 
of sterol A22-desaturase for cell survival by gene disruption 
techniques, the relative proportions and regulation of both 
sterol biosynthesis P450s under different physiological condi- 
tions, as well as structure/function studies. P450 51A1 is an 
important arget for antifungal drugs and agrochemicals [12] 
and information about P450 61 may allow further such devel- 
opments. P450 61 may also be involved in determining the 
overall sensitivity of cells to antifungal azole compounds which 
inhibit P450 51A1. The P450 61 gene can now be identified as 
one of last genes of ergosterol biosynthesis to be cloned. Sterol 
14c~-demethylase is possibly the oldest of the P450s being found 
in animals, plants, fungi and some bacteria [2]. Study on the 
evolution of 22-desaturase may also be interesting since this 
biotransformation is unique to fungal sterols and must have 
arisen at an early stage of their isolation from other Kingdoms. 
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